Roflumilast: a guide to its use in chronic obstructive pulmonary disease

被引：0
|
作者：
机构：
来源：
Drugs & Therapy Perspectives | 2011年 / 27卷 / 9期
关键词：
D O I：
10.2165/11206470-000000000-00000
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6 / 10
页数：4
相关论文
共 50 条
  • [21] Roflumilast: A new phosphodiesterase 4 inhibitor for chronic obstructive pulmonary disease
    Baker, Erica L.
    Baker, William L.
    FORMULARY, 2010, 45 (01) : 6 - 13
  • [22] Roflumilast in chronic obstructive pulmonary disease: evidence from large trials
    Cazzola, Mario
    Picciolo, Stefano
    Matera, Maria G.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (03) : 441 - 449
  • [23] Efficacy Of Roflumilast In Current And Former Smokers With Chronic Obstructive Pulmonary Disease
    Hanania, N. A.
    Dransfield, M. T.
    Goehring, U. -M.
    Lakkis, H.
    Rowe, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [24] Comparative Effectiveness of Roflumilast and Azithromycin for the Treatment of Chronic Obstructive Pulmonary Disease
    Lam, Jenny
    Tonnu-Mihara, Ivy
    Kenyon, Nicholas J.
    Kuhn, Brooks T.
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2021, 8 (04): : 450 - 463
  • [25] Risk factors for the discontinuation of roflumilast in patients with chronic obstructive pulmonary disease
    Kim, Kyung Hoon
    Kang, Hye Seon
    Kim, Ju Sang
    Yoon, Hyoung Kyu
    Kim, Sung Kyoung
    Rhee, Chin Kook
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 3449 - 3456
  • [26] Roflumilast And Chronic Obstructive Pulmonary Disease Exacerbation: Who At Risk For Indication?
    Sadigov, A.
    Bagirov, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [27] Olodaterol: A Review of Its Use in Chronic Obstructive Pulmonary Disease
    Deeks, Emma D.
    DRUGS, 2015, 75 (06) : 665 - 673
  • [28] Olodaterol: A Review of Its Use in Chronic Obstructive Pulmonary Disease
    Emma D. Deeks
    Drugs, 2015, 75 : 665 - 673
  • [29] RISK OF DIARRHEA IN ADULT PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE TAKING ROFLUMILAST
    Asfaw, A. A.
    Lee, I
    Lee, T. A.
    Sharp, L. K.
    Wilken, L.
    Joo, M.
    Calip, G. S.
    VALUE IN HEALTH, 2020, 23 : S356 - S356
  • [30] The role of the phosphodiesterase-4 inhibitor, roflumilast, in chronic obstructive pulmonary disease
    Wedzicha, Jadwiga A.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2010, 120 (1-2): : 9 - 10
12345